neoGMP®

Fast Track To Personalized Therapy

neoGMP® Service

neoGMP® produces unique plasmid DNA for each patient at a small scale, compared to a single, large-scale lot for many patients. The service supports the requirements for rapid production from a patient-specific sequence while maintaining the high quality you expect from Aldevron.

Plasmid DNA in Neoantigen Therapy-2

 

Features of neoGMP®

  • Rapid turnaround
  • Single-use, product-dedicated materials and equipment
  • Options for parallel processing
  • Quality oversight of key processes and parameters
  • Segregated manufacturing

► Download the neoGMP Service Flyer

Aldevron Advantage

  • 22+ year track record in DNA manufacturing
  • Regulatory experience
  • Process optimization expertise
  • Investments in manufacturing process development

neoGMP® Resources

GMP-S Gene Synthesis

ALD-Neo-Gene-Synthesis
 
Designed to meet the needs of rapid clinical gene synthesis for novel cancer treatments based on neoantigens.
 
Learn more about our GMP-Source® Gene Synthesis Service.
 

Press Release

ALD-NeoGMP-Data
 
Aldevron has experience bringing neoantigen vaccines to the commercial market.
 
Learn more about our collaboration with Ziopharm Oncology. 
 

Connect with an Expert

ALD-Connect-Expert
 
Connect with us to learn more about how our neoGMP® service can be customized to fit your specific neoantigen projects.
 
Connect with one of our neoGMP experts to discuss your project.